Orelle

Orelle is a biotechnology and consumer health company focused on advancing mitochondrial health and longevity through science-backed interventions. Co-founded by renowned longevity researcher Dr. David Sinclair, the company leverages insights into mitochondrial biology to develop products that support cellular energy production and metabolic function. Orelle's primary focus is on the commercialization of high-purity compounds, such as Urolithin A, which are designed to trigger mitophagy and rejuvenate aging cells. By bridging the gap between clinical research and consumer wellness, Orelle aims to provide accessible solutions for maintaining healthspan and combating age-related decline.